The genes of the known and putative glycosyltransferases POMT1/2, POMGnT1, LARGE1, LARGE2, fukutin and FKRP, which are involved in α-DG modification are affected in human congenital neuromuscular diseases, so-called "secondary dystroglycanopathies", that manifest in a range of muscular and brain abnormalities caused by a loss of function of DG as an ECM receptor [1], [4], [5].
We therefore tested whether Slx5 was SUMOylated and, if so, whether its modification was affected by ULS1.
Even so, earlier studies have provided some evidence of physiological changes in nodosities upon attack by this insect (e.g. Forneck et al. 2001b; Kellow et al. 2004; Du et al. 2011) arguing that not only genes involved in cell wall modification are affected.
We next addressed how patterns of chromatin modifications were affected at an X centromere before and after it was structurally altered.
Since TFE3 post-translational modifications were affected by FLCN, we examined whether FLCN expression could regulate TFE3 subcellular localization after cellular fractionation to yield cytoplasmic, soluble and insoluble nuclear fractions.
Our results corroborate previous observations indicating that different cell envelope modifications were affected at low temperature in the gram-negative Psychrobacter arcticus [ 50].
These modifications are affected by histone-lysine (and histone-arginine) N-methyltransferase enzymes (Table 18) by which these proteins may be further modified by acetylation, ADP-ribosylation, ubiquination, and phosphorylation (annotation not tabulated).
All the epigenetic modifications are affected by environmental signals and their dysregulation can lead to many diseases including MS. Patients with MS have been found to share specific epigenetic modifications (Table 2), yet the functional role of such aberrancies in the disease development is not completely understood.
In addition, we show how the transistor behaviour of an amorphous polymer low-voltage transistor is affected by modification of the Al2O3 dielectric with self-assembled monolayers of molecules with different functional groups.
Uptake of azole antifungal drugs is believed to be via passive diffusion through the cell wall and is affected by modification of cell wall structure by altering the glycosylation of surface proteins.
